Physician profile
Suchet Kumar
NPI 1285012211
$8,526.85
in general payments reported to CMS, 2019-2025
26 companies · $1,026 in 2025
The $1,026 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,354 · 2020: $809 · 2021: $2,055 · 2022: $902 · 2023: $612 · 2024: $769 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,407.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,136.21 | 2021-2025 | Symplicity G3 |
| Abiomed | $912.47 | 2019-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $784.18 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $671.44 | 2019-2021 | |
| Abbott Laboratories | $488.37 | 2021-2025 | Aveir, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $470.08 | 2019-2025 | Camzyos |
| Boston Scientific Corporation | $468.68 | 2019-2025 | Varithena Administration Pack, Rotapro, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $391.39 | 2019-2024 | Jardiance |
| Amarin Pharma, INC. | $355.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $350.93 | 2019-2022 | |
| Shockwave Medical, INC | $325.42 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $278.07 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $264.68 | 2024-2025 | |
| Novo Nordisk INC | $242.35 | 2024 | |
| Pfizer INC. | $211.24 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $206.36 | 2019-2021 | |
| Amgen INC. | $194.69 | 2019-2022 | |
| Penumbra, INC. | $162.51 | 2021-2022 | |
| Insulet Corporation | $139.00 | 2025 | Omnipod |
| Philips North America LLC | $136.28 | 2025 | Ht Bilevel Pro Core |
| Edwards Lifesciences Corporation | $112.95 | 2020-2021 | |
| Astellas Pharma US INC | $79.99 | 2021 | |
| Terumo Medical Corporation | $60.93 | 2019-2022 | |
| Chiesi USA, INC. | $46.31 | 2021-2022 | |
| Medtronic Vascular, INC. | $27.15 | 2020 | |
| Cardiovascular Systems INC. | $9.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suchet Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.